 |
 |
Tom Reiss writes: >I have seen many recent postings on Amgen and GDNF and while this appears to >be a very promising area of research I wonder how many of you are aware of the >work being done at Guilford Pharmaceutical where they will shortly begin human >clinical trials of a much smaller molecule (small enough to cross the >blood-brain barrier) and shown to be very effective in reversing the effects of >PD in primates by regenerating nerve growth. > Hi Tom, Good to hear from you again! I think I may have met you at the Tucson APDA meeting 3 or 4 years ago when you (and I think you were with Alan Bonander??) did a demonstration on blue glasses. It was very interesting, and a number of PWP's in Tucson now sport blue glasses! I think you also spoke about the infusion experiment that you were involved in. Or has my short term memory loss turned into a long term one also? I didn't know it was possible to have 4 pallidotomies, is this because of an increasing electrical malfunction in the brain, or because one operation doesn't fix everything? I guess I'm asking the philosophy behind this progressive approach. And PLEASE...more info on the smaller molecule! What is it called and how does it work?! Curious minds want to know! Or is it Girls just want to have fun? I get my cliches mixed up these days :) Kathie Tollifson [log in to unmask] 46/8